NASDAQ:CNTX

Context Therapeutics Stock Signals

etoro logo Buy CNTX
*Your capital is at risk
$1.15
-0.0100 (-0.86%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.343 3 days ( 0 % )
Last Price $1.15 -0.86 %
High/ Low $1.14 - $1.19 5.70%
Chg 7 Days -4.17 % $1.20 $1.15
Chg 30 Days -20.14 % $1.44 $1.15
Chg 12 mos -37.50 % $1.84 $1.15
Trend - 3 mos 41.81 % Width: 42.16 %
Trend - 12 mos -9.51 % Width: 213.49 %
Pred. range - 3 mos $1.59 - $2.26 38.28 % - 96.58 %
Pred. range - 12 mos $0.412 - $1.29 -64.17 % - 12.31 %
Short MA avg 3 mos Sell Nov 12, 2025 - 4 days
Long MA avg 3 mos Sell Nov 12, 2025 - 4 days
Short/Long MA avg 3 mos Sell Nov 03, 2025 - 11 days
Short MA avg 12 mos Sell Oct 27, 2025 - 16 days
Long MA avg 12 mos Buy Aug 13, 2025 - 68 days
Short/Long MA avg 12 mos Buy Jul 24, 2025 - 82 days
Pivot Short Sell Oct 17, 2025 - 22 days
Bollinger Buy Sep 19, 2025 - 42 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT CONTEXT THERAPEUTICS INC.
Context Therapeutics
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also dev...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE